(E)-2-(2-((1H-imidazol-5-yl)methylene)hydrazinyl)quinoxaline

ID: ALA4645649

PubChem CID: 156019547

Max Phase: Preclinical

Molecular Formula: C12H10N6

Molecular Weight: 238.25

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C(=N/Nc1cnc2ccccc2n1)\c1cnc[nH]1

Standard InChI:  InChI=1S/C12H10N6/c1-2-4-11-10(3-1)14-7-12(17-11)18-16-6-9-5-13-8-15-9/h1-8H,(H,13,15)(H,17,18)/b16-6+

Standard InChI Key:  MTSSNTTXKFNVPU-OMCISZLKSA-N

Molfile:  

 
     RDKit          2D

 18 20  0  0  0  0  0  0  0  0999 V2000
   16.8377  -10.7596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8365  -11.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5446  -11.9881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5428  -10.3508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2514  -10.7560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2522  -11.5751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9607  -11.9821    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.6690  -11.5713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6642  -10.7492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9551  -10.3458    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.3694  -10.3363    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.0796  -10.7406    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.7848  -10.3277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4950  -10.7319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5864  -11.5422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3868  -11.7072    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.7911  -10.9970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2405  -10.3931    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 14  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4645649

    ---

Associated Targets(Human)

OVCAR-8 (47708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 238.25Molecular Weight (Monoisotopic): 238.0967AlogP: 1.80#Rotatable Bonds: 3
Polar Surface Area: 78.85Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.33CX Basic pKa: 6.04CX LogP: 1.52CX LogD: 1.51
Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.54Np Likeness Score: -1.37

References

1. Maranhão SS, Moura AF, Oliveira ACA, Lima DJB, Barros-Nepomuceno FWA, Paier CRK, Pinheiro AC, Nogueira TCM, de Souza MVN, Pessoa C..  (2020)  Synthesis of PJOV56, a new quinoxalinyl-hydrazone derivative able to induce autophagy and apoptosis in colorectal cancer cells, and related compounds.,  30  (2): [PMID:31836446] [10.1016/j.bmcl.2019.126851]

Source